SOON-SHIONG PATRICK
SEC insider (Form 3/4/5 filer). CIK 0001189020. Director & 10% Owner at PDS Biotechnology Corp (PDSB) and 1 other issuer. 13 reported Form 4/5 transactions since Sep 2024; latest on Mar 31, 2026. Located in PRINCETON, NJ.
Companies SOON-SHIONG PATRICK has filed insider reports for
- PDS Biotechnology Corp (PDSB): Director, 10% Owner
- ImmunityBio, Inc. (IBRX): Director, Officer, 10% Owner, See remarks
SOON-SHIONG PATRICK
CIK: 0001189020
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Mar 31, 2026IBRX
ImmunityBio, Inc.
ConversionIndirect4.6M shares at avg. $5.43$25.0M - Feb 22, 2026IBRX
ImmunityBio, Inc.
Tax PaymentDirect58.2K shares at avg. $8.70$506K - Feb 22, 2026IBRX
ImmunityBio, Inc.
ExerciseDirect114.3K shares- - Feb 10, 2026IBRX
ImmunityBio, Inc.
ExerciseDirect274.1K shares- - Feb 10, 2026IBRX
ImmunityBio, Inc.
Tax PaymentDirect118.6K shares at avg. $6.93$822K - Feb 22, 2025IBRX
ImmunityBio, Inc.
ExerciseDirect114.3K shares- - Feb 22, 2025IBRX
ImmunityBio, Inc.
Tax PaymentDirect42.1K shares at avg. $3.42$144K - Feb 10, 2025IBRX
ImmunityBio, Inc.
AwardDirectRestricted Stock Units
822.4K shares- - Feb 10, 2025IBRX
ImmunityBio, Inc.
AwardDirectStock Option (right to buy)
2.8M shares- - Dec 10, 2024IBRX
ImmunityBio, Inc.
ConversionIndirect103.7M shares at avg. $1.94$200.7M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 31, 2026 | IBRX ImmunityBio, Inc. | Conversion | 4,606,596 | $5.43 | $24,999,996 | Indirect |
| Feb 22, 2026 | IBRX ImmunityBio, Inc. | Tax Payment | 58,170 | $8.70 | $506,079 | Direct |
| Feb 22, 2026 | IBRX ImmunityBio, Inc. | Exercise | 114,329 | - | $0 | Direct |
| Feb 10, 2026 | IBRX ImmunityBio, Inc. | Exercise | 274,122 | - | $0 | Direct |
| Feb 10, 2026 | IBRX ImmunityBio, Inc. | Tax Payment | 118,560 | $6.93 | $821,621 | Direct |
| Feb 22, 2025 | IBRX ImmunityBio, Inc. | Exercise | 114,329 | - | - | Direct |
| Feb 22, 2025 | IBRX ImmunityBio, Inc. | Tax Payment | 42,071 | $3.42 | $143,883 | Direct |
| Feb 10, 2025 | IBRX ImmunityBio, Inc. | Award Restricted Stock Units | 822,368 | - | - | Direct |
| Feb 10, 2025 | IBRX ImmunityBio, Inc. | Award Stock Option (right to buy) | 2,812,500 | - | - | Direct |
| Dec 10, 2024 | IBRX ImmunityBio, Inc. | Conversion | 103,710,088 | $1.94 | $200,679,020 | Indirect |
1-10 of 13 transactions